Primary care and prescription drugs: coverage, cost-sharing, and financial protection in six European countries.
This issue brief describes coverage, cost-sharing, and financial protection for pri-mary care and prescription drugs in Denmark, England, France, Germany, the Netherlands, and Sweden. Very few patients report unmet need for care or find general practitioner care unaffordable. Although none of the six countries spends more than 11 percent of gross domes-tic product on health care, compared with 16.2 percent in the United States, they are able to provide a level of access to and financial protection for primary care and prescription drugs that far exceeds what is available in the U.S. Several have focused recently on adapting cost-sharing design to reflect value by reducing user charges for highly effective care, preventive care, accepting referral to specialist care, adhering to clinical guidelines, and enrollment in dis-ease management programs. These innovations, and others described in the brief, could help inform U.S. policies for national health insurance reform.
Thomson
Sarah
S
LSE Health, London School of Economics and Political Science, London, England. S.Thomson@lse.ac.uk
Mossialos
Elias
E
D017047:Cost Sharing / Q000191:economics*; D017850:Economics, Pharmaceutical; D005060:Europe; D018166:Health Care Reform / Q000191:economics; D006801:Humans; D019458:Insurance Coverage / Q000191:economics*; D007348:Insurance, Health / Q000191:economics*; D007356:Insurance, Pharmaceutical Services / Q000191:economics*; D011050:Policy Making; D055553:Prescription Drugs / Q000191:economics*; D011320:Primary Health Care / Q000191:economics*; D017149:Private Sector; D017150:Public Sector; D014481:United States
D055553:Prescription Drugs